Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.01712 | 42 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.9421 | 41 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.94836 | 41 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.84765 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.88693 | 41 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.00928 | 40 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.9962 | 41 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.91374 | 40 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.98077 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.90903 | 40 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.92884 | 41 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.89379 | 40 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.94955 | 41 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.93623 | 41 |